These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 12010767)

  • 1. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
    Naidu PS; Singh A; Kulkarni SK
    Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
    Naidu PS; Singh A; Kulkarni SK
    Neuropharmacology; 2003 Jun; 44(8):1100-6. PubMed ID: 12763102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
    Singh A; Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2003 Sep; 477(2):87-94. PubMed ID: 14519411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia.
    Naidu PS; Singh A; Kaur P; Sandhir R; Kulkarni SK
    Pharmacol Biochem Behav; 2003 Feb; 74(3):641-8. PubMed ID: 12543230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals.
    Patil R; Hiray Y; Shinde S; Langade P
    Pharm Biol; 2012 Jun; 50(6):691-7. PubMed ID: 22136413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
    Bishnoi M; Chopra K; Kulkarni SK
    Psychopharmacology (Berl); 2008 Feb; 196(2):243-54. PubMed ID: 17955214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
    Dhingra D; Goswami S; Gahalain N
    Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
    Naidu PS; Singh A; Kulkarni SK
    Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):601-5. PubMed ID: 18193111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action.
    Naidu PS; Singh A; Kulkarni SK
    J Med Food; 2003; 6(2):107-14. PubMed ID: 12935321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
    Naidu PS; Singh A; Kulkarni SK
    Psychopharmacology (Berl); 2003 Jun; 167(4):418-23. PubMed ID: 12669184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.
    Sanghavi CR; Barhate SA; Mahajan MS; Mohan M; Kasture SB
    Nat Prod Res; 2011 Apr; 25(7):704-15. PubMed ID: 20628966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 May; 420(2-3):113-7. PubMed ID: 11408032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
    Naidu PS; Singh A; Kulkarni SK
    Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation.
    Datta S; Jamwal S; Deshmukh R; Kumar P
    Eur J Pharmacol; 2016 Jan; 771():229-35. PubMed ID: 26712377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.